Surrozen, Inc. (SRZN) analyst actions
Rating and price-target actions on SRZN in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the SRZN overview →
1 measured SRZN analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis | Press release | — | -2.11% |
Keep exploring
More SRZN: earnings → · SEC filings → · SRZN overview →